Teva Pharmaceutical Industries Limited (TEVA) financial statements (2021 and earlier)

Company profile

Business Address 5 BAZEL ST
PETACH TIKVA, 49131
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9751,782963
Cash and cash equivalents1,9751,782963
Receivables5,6765,8227,927
Inventory, net of allowances, customer advances and progress billings4,4224,7314,924
Inventory4,4224,7314,924
Prepaid expense870899 
Disposal group, including discontinued operation8792 
Other current assets434468 
Other undisclosed current assets  1,568
Total current assets:13,46413,79415,382
Noncurrent Assets
Finance lease, right-of-use asset37
Operating lease, right-of-use asset514
Property, plant and equipment6,4366,8687,673
Intangible assets, net (including goodwill)36,07838,92246,054
Goodwill24,84624,91728,414
Intangible assets, net (excluding goodwill)11,23214,00517,640
Other noncurrent assets591731932
Deferred tax assets, net (2,703)
Other undisclosed noncurrent assets3503683,277
Total noncurrent assets:44,00646,88955,233
TOTAL ASSETS:57,47060,68370,615
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,7181,8532,069
Employee-related liabilities693870 
Other undisclosed accounts payable and accrued liabilities1,0259832,069
Debt2,3452,2163,646
Other liabilities889804724
Other undisclosed current liabilities8,7229,44911,482
Total current liabilities:13,67414,32217,921
Noncurrent Liabilities
Long-term debt and lease obligation24,99726,70028,829
Long-term debt, excluding current maturities24,56226,70028,829
Operating lease, liability435
Liabilities, other than long-term debt2,6403,8675,120
Deferred tax liabilities, net2,1403,277
Other liabilities2,6401,7271,843
Other undisclosed noncurrent liabilities1,096  
Total noncurrent liabilities:28,73330,56733,949
Total liabilities:42,40744,88951,870
Stockholders' equity
Stockholders' equity attributable to parent13,97214,70717,359
Preferred stock  3,631
Common stock565654
Treasury stock, value(4,128)(4,142)(4,149)
Additional paid in capital27,31227,21023,479
Accumulated other comprehensive loss(2,312)(2,459)(1,853)
Accumulated deficit(6,956)(5,958)(3,803)
Stockholders' equity attributable to noncontrolling interest1,0911,0871,386
Total stockholders' equity:15,06315,79418,745
TOTAL LIABILITIES AND EQUITY:57,47060,68370,615

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Revenues16,88718,85423,584
Revenue, net22,385
Cost of revenue
(Cost of Goods and Services Sold)
(9,351)(10,558)(11,560)
Other undisclosed gross profit1 (1,199)
Gross profit:7,5378,29610,825
Operating expenses(4,816)(4,147)(4,986)
Other operating income, net76  
Other undisclosed operating loss(3,240)(5,786)(23,323)
Operating loss:(443)(1,637)(17,484)
Nonoperating expense(822)(959)(895)
Interest and debt expense(881)(920)(875)
Other undisclosed income from continuing operations before equity method investments, income taxes881920875
Loss from continuing operations before equity method investments, income taxes:(1,265)(2,596)(18,379)
Loss from equity method investments(13)(71)(3)
Loss from continuing operations before income taxes:(1,278)(2,667)(18,382)
Income tax benefit2781951,933
Net loss:(1,000)(2,472)(16,449)
Net income attributable to noncontrolling interest2322184
Other undisclosed net loss attributable to parent(1)  
Net loss attributable to parent:(999)(2,150)(16,265)
Preferred stock dividends and other adjustments (249)(260)
Net loss available to common stockholders, diluted:(999)(2,399)(16,525)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(1,000)(2,472)(16,449)
Other comprehensive income (loss)160(585)1,306
Other undisclosed comprehensive income  184
Comprehensive loss:(840)(3,057)(14,959)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(12)296184
Other undisclosed comprehensive loss, net of tax, attributable to parent  (305)
Comprehensive loss, net of tax, attributable to parent:(852)(2,761)(15,080)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: